# Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

> **NCT00082628** · PHASE3 · COMPLETED · sponsor: **EMD Serono** · enrollment: 326 (actual)

## Conditions studied

- HIV Infections
- Lipodystrophy

## Interventions

- **DRUG:** Placebo
- **DRUG:** Serostim® 4 mg
- **DRUG:** Serostim® 2 mg

## Key facts

- **NCT ID:** NCT00082628
- **Lead sponsor:** EMD Serono
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05-28
- **Primary completion:** 2005-09-28
- **Final completion:** 2005-09-28
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2018-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00082628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00082628, "Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00082628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*